Stella Pharma Corporation

TSE:4888 Stock Report

Market Cap: JP¥17.1b

Stella Pharma Management

Management criteria checks 2/4

Stella Pharma's CEO is Koki Uehara, appointed in Jun 2020, has a tenure of 4.42 years. directly owns 0.021% of the company’s shares, worth ¥3.51M. The average tenure of the management team and the board of directors is 2.4 years and 6.4 years respectively.

Key information

Koki Uehara

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.4yrs
CEO ownership0.02%
Management average tenure2.4yrs
Board average tenure6.4yrs

Recent management updates

Recent updates


CEO

Koki Uehara (47 yo)

4.4yrs

Tenure

Mr. Koki Uehara is President at Stella Pharma Corporation since June 2020 and serves as its Representative Director since June 2020. He was Chief Operating Officer of Stella Pharma Corporation until June 2...


Leadership Team

NamePositionTenureCompensationOwnership
Koki Uehara
President & Representative Director4.4yrsno data0.021%
¥ 3.5m
Toshimitsu Hayashi
GM of Pharmaceutical Affairs & Clinical Development Department and Director2.4yrsno data0.0059%
¥ 1.0m
Takahiro Kido
GM of Corporate Planning Department & Director2.4yrsno data0.0026%
¥ 451.0k

2.4yrs

Average Tenure

47yo

Average Age

Experienced Management: 4888's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Koki Uehara
President & Representative Director12yrsno data0.021%
¥ 3.5m
Toshimitsu Hayashi
GM of Pharmaceutical Affairs & Clinical Development Department and Director2.4yrsno data0.0059%
¥ 1.0m
Takahiro Kido
GM of Corporate Planning Department & Director2.4yrsno data0.0026%
¥ 451.0k
Kazumitsu Yabu
Director21.4yrsno data0.015%
¥ 2.5m
Masaya Onishi
Independent Outside Director6.4yrsno datano data
Kohei Tsujii
Independent Outside Director6.4yrsno datano data

6.4yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 4888's board of directors are considered experienced (6.4 years average tenure).